Table 4 |
||||
|
Response rates of subjects to treatment based on pain assessments. |
||||
|
4 Weeks |
8 Weeks |
|||
|
|
||||
|
Criteria |
Glucosamine (n = 47) |
Reparagen (n = 48) |
Glucosamine (n = 47) |
Reparagen (n = 48) |
|
|
||||
|
20% decrease in WOMAC pain |
74.5 |
81.2 |
89.4 |
93.7 |
|
20% decrease in WOMAC pain & 10 mm VAS Pain |
66.0 |
68.7 |
85.1 |
91.7 |
|
50% decrease in WOMAC pain |
38.2 |
58.3* |
72.3 |
77.1 |
|
50% decrease in WOMAC pain & 20 mm VAS Pain |
25.5 |
37.5 |
63.8 |
72.9 |
|
|
||||
|
Percentage of subjects meeting various criteria for response to treatment. Results between reparagen (n = 48) and glucosamine sulfate (n = 47) were not significantly different using these criteria except where denoted by the * (P = 0.05). |
||||
|
Mehta et al. BMC Complementary and Alternative Medicine 2007 7:34 doi:10.1186/1472-6882-7-34 |
||||
